Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106282134A details KgQR enzyme for high yield synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN106117113A details a novel ammonium iodide catalyzed one-pot synthesis for polysubstituted carbazoles, offering significant cost reduction and supply chain reliability for optoelectronic and pharmaceutical intermediates.
Patent CN113372315B details a robust method for synthesizing C-glucoside impurities, ensuring reliable supply chains and cost-effective API manufacturing for diabetes treatments.
Patent CN113527141B reveals a metal-free organocatalytic route for spiro[2,5]octane derivatives, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN110438194B details a novel lipase F11 for resolving DL-tropine methyl ester with >99% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN102876734B details a novel carbonyl reductase for high-purity chiral alcohol production, offering significant cost and supply chain advantages for API intermediates.
Patent CN111500652A reveals a novel enzymatic dynamic kinetic resolution for florfenicol. Discover cost-effective, high-purity veterinary drug intermediate manufacturing solutions.
Patent CN109609536B reveals efficient whole-cell synthesis. Reduces cost and improves supply chain reliability for high-purity L-carnosine manufacturing.
Patent CN111172127A reveals high-efficiency sucrose phosphorylase method. Offers cost reduction and supply chain reliability for functional skincare ingredients manufacturing.
Patent CN109609536B enables efficient L-carnosine production. Reduced costs and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN1468212A introduces a safe, cost-effective asymmetric cyanation method using alkali metal cyanides and chiral titanium catalysts for high-purity pharmaceutical intermediates.
Patent CN115896060A reveals a novel ω-transaminase mutant for silodosin synthesis, offering >99% ee and scalable biocatalysis for reliable supply chains.
Patent CN103360410B details a novel trimethylchlorosilane protection route enhancing yield and purity for scalable Ofloxacin USP 23 manufacturing supply chains.
Patent CN112143688A reveals a novel recombinant E. coli strain for high-purity (S)-CHBE production, offering significant cost reduction in API manufacturing.
Patent CN109096048A reveals advanced hydration method. Offers cost reduction and supply reliability for synthetic flavors and fragrances manufacturing.
Patent CN113583992A reveals a novel RsRedAm enzyme for efficient secondary amine synthesis, offering mild conditions and high selectivity for pharmaceutical intermediates.
Patent CN110382705B details a novel enzymatic route for L-Alanyl-L-Glutamine using engineered acyltransferase, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN1376659A reveals a safe metal borohydride reduction system for high-purity chiral intermediates, offering significant cost and supply chain advantages.
Patent CN115537405A reveals a novel ketoreductase mutant for high-purity (S)-1-(3-chlorophenyl)-1,3-propanediol production, offering significant cost reduction in API manufacturing.
Patent CN101117317B details a novel Heck reaction process for resveratrol. Discover cost-effective manufacturing and supply chain advantages for high-purity intermediates.